1 Jain KS, Kathiravan MK, Somani RS, Shishoo CJ. The biology and chemistry of hyperlipidemia. Bioorg Med Chem. 2007; 15(14):4674-99.

2 Keenan JM. Treatment of patients with lipid disorders in the primary care setting: new treatment guidelines and their implications. South Med J. 2003; 96(3):266-75.

3 Havel RJ, Rappaport E. Management of primary hyperlipidemia. N Engl J Med. 1995; 332:14491-9.

4 Huang TL, Chen JF. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis, and inflammation and immunity. Adv Clin Chem. 2005; 39:81-105.

5 Korea Health Industry Development Institute. Drug industry analysis statement in 2008.

6 Kim JK, Song JH, Cho HI, Kim SI. Survey Result on the Prevalence of Hyperlipidemia and Other Risk Factors of Coronary Artery Disease Among Korean Population. J Korean Clinical Pathology. 1991; 11(2):341-7.

7 Kim YH, Kim JK, Lee SW, Lim ST, Cha GW, Cho YJ, et al. The 10-years follow up study on serum total cholesterol levels in normal Korean adult male workers living in Pohang. J Korean Med. 2003; 65(6):675-81.

8 hoi MJ. Relations of Life Style, Nutrient Intake, and Blood Lipids in Middle-Aged Men with Borderline Hyperlipidemia. J Korean Community Nutrition. 2005; 10(3):281-9.

9 Korea National Statistical Office. Summary Report of the Cause of Death Statistics in 2008.

10 Shin WT, Heo JE, Kim TH, Hong SH, Kwon OS, Kim KT, et al. Clinical effect of Dodam-tang on hyperlipidemia patients. J. Orient. Int. Med. 2007; Fall:113-8.

11 Kim BC, Lee EJ, Park CS, Park CG. The experimental study on the effects of Dansamyeum on hyperlipidemia. J. Orient. Int. Med. 2000; 21:126-34.

12 Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, et al. The prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults. J Korean Med. 2005; 68(4):359-68.

13 Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part I. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetic Med. 1998; 15:539-53.

14 Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Execute summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III ). JAMA. 2001; 285: 2486-97.

15 Division of Disease Control Policy in Ministry for Health, Welfare and Family Affairs. Introduction of Major Chronic Disease Management Industry in 2009.

16 Chapman MJ. The potential role of HDL- and LDL-cholesterol modulation in atheromatous plaque development. Curr Med Res Opin. 2005;21(Suppl 6):S17-22.

17 Taskinen MR. LDL-cholesterol, HDL-cholesterol or triglycerides - which is the culprit? Diabetes Res Clin Pract. 2003; 61(Suppl 1):S19-26.

18 Havel RJ, Rappaport E. Management of primary hyperlipidemia. N Engl J Med. 1995; 332:14491-9.

19 Choi KM, Cho YJ, Kim KO, Kim DR, Kim NH, Ahn JC, et al. Prevalence of Obesity and Correlation Between Obesity and Dyslipidemia in Elderly Population in South-West Seoul. J Korean Geriatr Soc. 2000; 4(3):119-28.

20 Shin YK, Bae SK, Chung WT, Lee MK, Lee DI, Moon CH. Lipid Distribution in Healthy Normal Korean Adults. J Korean Med. 1994; 47(5):587-602.